Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 19.98 | N/A |
| PEG Ratio (TTM) | 2.51 | N/A |
| P/S Ratio (TTM) | 0.69 | N/A |
| P/B Ratio (TTM) | 1.84 | N/A |
| P/FCF Ratio (TTM) | 7.30 | N/A |
| Price to 5YR AVG Earnings Ratio | 12.32 | N/A |
| Price to 5YR AVG FCF Ratio | 11.76 | N/A |
Profitability (35%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 4.33% | N/A |
| ROE (TTM) | 9.48% | N/A |
| Net Profit Margin (TTM) | 3.47% | N/A |
| ROIC 5YR AVG | 13.85% | N/A |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 387.75% | 29.21% | 8.13% |
| Revenue | -0.34% | 24.55% | 12.55% |
| Net Income | 388.46% | 29.46% | 8.38% |
| Cash Flow | 618.77% | -30.09% | 107.45% |
Health (74%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.88 | N/A |
| Quick Ratio (TTM) | 1.25 | N/A |
| D/E Ratio (TTM) | 0.58 | N/A |
| Interest Coverage (TTM) | 6.16 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 3.34 | N/A |
| LTL to 5YR AVG FCF | 4.81 | N/A |
| Shares Outstanding Growth 5YR AVG | 0.10% | N/A |